| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3806 |
| Trial ID | NCT06316791 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CNCT19|inaticabtagene autoleucel |
| Location approved | China |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases |
| Year | 2021 |
| Country | China |
| Company sponsor | Juventas Cell Therapy Ltd. |
| Other ID(s) | HY001007 |
| Cohort 1 | |||||||||
|
|||||||||